PubRank
Search
About
David C Gotley
Author PubWeight™ 31.47
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.
Lancet Oncol
2005
5.40
2
Comparison of the outcomes between open and minimally invasive esophagectomy.
Ann Surg
2007
2.60
3
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer.
Genome Res
2013
2.57
4
Radiofrequency ablation of liver tumors: a systematic review.
Arch Surg
2006
2.22
5
Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial.
Eur J Cancer
2011
1.54
6
Genome-wide copy number analysis in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arrays.
Cancer Res
2008
1.50
7
Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus.
Cancer Epidemiol Biomarkers Prev
2005
1.49
8
Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia.
Clin Cancer Res
2005
1.48
9
Factors associated with postoperative pulmonary morbidity after esophagectomy for cancer.
Ann Surg Oncol
2010
1.24
10
Expression of the CD44v2-10 isoform confers a metastatic phenotype: importance of the heparan sulfate attachment site CD44v3.
Cancer Res
2003
1.13
11
Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis.
Thromb Haemost
2003
1.08
12
Defining cure for esophageal cancer: analysis of actual 5-year survivors following esophagectomy.
Ann Surg Oncol
2011
1.05
13
Expression of the cell surface mucin gene family in adenocarcinomas.
Int J Oncol
2004
1.04
14
Risk stratification for early esophageal adenocarcinoma: analysis of lymphatic spread and prognostic factors.
Ann Surg Oncol
2010
1.00
15
Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma.
Mol Cancer
2008
0.97
16
Whole genome expression array profiling highlights differences in mucosal defense genes in Barrett's esophagus and esophageal adenocarcinoma.
PLoS One
2011
0.94
17
Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
Ann Surg Oncol
2008
0.86
18
Thoracoscopic-assisted esophagectomy for esophageal cancer: analysis of patterns and prognostic factors for recurrence.
Ann Surg
2010
0.86
19
Treatment results of curative gastric resection from a specialist Australian unit: low volume with satisfactory outcomes.
Gastric Cancer
2013
0.81
20
Feasibility of chemoradiation therapy with protracted infusion of 5-fluorouracil for esophageal cancer patients not suitable for cisplatin.
Int J Clin Oncol
2005
0.80
21
Tumor progression in hepatocellular carcinoma: relationship with tumor stroma and parenchymal disease.
J Gastroenterol Hepatol
2003
0.79
22
Symptoms, investigations and management of patients with cancer of the oesophagus and gastro-oesophageal junction in Australia.
Med J Aust
2010
0.76
23
Consideration of mesh-related complications.
Ann R Coll Surg Engl
2008
0.75
24
Long-term Health-related Quality of Life Following Esophagectomy: A Nonrandomized Comparison of Thoracoscopically Assisted and Open Surgery.
Ann Surg
2017
0.75